A.L. Willis

5.7k total citations · 2 hit papers
56 papers, 4.2k citations indexed

About

A.L. Willis is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Biochemistry. According to data from OpenAlex, A.L. Willis has authored 56 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 13 papers in Cardiology and Cardiovascular Medicine and 12 papers in Biochemistry. Recurrent topics in A.L. Willis's work include Inflammatory mediators and NSAID effects (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Eicosanoids and Hypertension Pharmacology (11 papers). A.L. Willis is often cited by papers focused on Inflammatory mediators and NSAID effects (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Eicosanoids and Hypertension Pharmacology (11 papers). A.L. Willis collaborates with scholars based in United States, United Kingdom and Poland. A.L. Willis's co-authors include J. Bryan Smith, Robert G. Feldman, Martin L. Albert, Douglas C. Kuhn, Donald L. Smith, Harvey J. Weiss, PB Kernoff, G. P. McNicol, K. J. Stone and Alan Anderson and has published in prestigious journals such as Science, New England Journal of Medicine and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

A.L. Willis

54 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets

1971 1.2k citations J. Bryan Smith, A.L. Willis profile →
The `subcortical dementia' of progressive supranuclear palsy

1974 614 citations A.L. Willis et al. profile →

Peers

Countries citing papers authored by A.L. Willis

Since Specialization

Citations

This map shows the geographic impact of A.L. Willis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.L. Willis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.L. Willis more than expected).

Fields of papers citing papers by A.L. Willis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.L. Willis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.L. Willis. The network helps show where A.L. Willis may publish in the future.

Co-authorship network of co-authors of A.L. Willis

This figure shows the co-authorship network connecting the top 25 collaborators of A.L. Willis. A scholar is included among the top collaborators of A.L. Willis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.L. Willis. A.L. Willis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Eicosanoids: An Introduction and An Overview 2017 ·A.L. Willis	1
2	Correlation Among On-Call Resident Study Volume, Discrepancy Rate, and Turnaround Time 2010 ·Academic Radiology ·(unknown), Michael Hoch, A.L. Willis, (unknown), (unknown), Beverly L. Hershey	31
3	Inhibition of platelet-derived mitogen release by nitric oxide (EDRF) 1989 ·Inflammation Research ·M. L. Barrett, A.L. Willis, John R. Vane	40
4	Selective anti‐platelet aggregation synergism between a prostacyclin‐mimetic, RS93427 and the nitrodilators sodium nitroprusside and glyceryl trinitrate 1989 ·British Journal of Pharmacology ·A.L. Willis, Donald L. Smith, (unknown), (unknown), (unknown), L. Hedley, (unknown)	11
5	Chemical and biochemical aspects 1987 ·CRC Press eBooks ·A.L. Willis	11
6	Suppression of principal atherosclerotic mechanisms by prostacyclinc and other eicosanoids 1986 ·Progress in Lipid Research ·A.L. Willis, Donald L. Smith, Carmen Vigo	59
7	Lack of Circulating Prostacyclin (PGI2) In Guinea Pig And Rat 1981 ·Thrombosis and Haemostasis ·(unknown), A.L. Willis, Darcey L.H. Smith, Diane Donegan	1
8	Unanswered questions in EFA and PG research 1981 ·Progress in Lipid Research ·A.L. Willis	18
9	A convenient method for isolation and bioassay of prostaglandins E1, E2, F2 and D2 [proceedings]. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·J. Denton, (unknown), A.L. Willis	1
10	Trimethoquinol is a potent prostaglandin endoperoxide antagonist [proceedings]. 1978 ·PubMed ·D. Euan MacIntyre, A.L. Willis	3
11	Antithrombotic potential of dihomo-gamma-linolenic acid in man. 1977 ·BMJ ·PB Kernoff, A.L. Willis, K. J. Stone, J A Davies, G. P. McNicol	117
12	Prostaglandin E₂ Potentiation of Platelet Aggregation Induced by LASS Endoperoxide: Absent in Storage Pool Disease, Normal after Aspirin Ingestion 1976 ·British Journal of Haematology ·Harvey J. Weiss, A.L. Willis, Douglas C. Kuhn, (unknown)	42
13	Acetylenic Analog of Arachidonate That Acts Like Aspirin on Platelets 1974 ·Science ·A.L. Willis, Douglas C. Kuhn, Harvey J. Weiss	36
14	Dihomo-γ-linolenate suppresses platelet aggregation when administered in vitro or in vivo 1974 ·Prostaglandins ·A.L. Willis, Karen Comai, Douglas C. Kuhn, J.R. Paulsrud	81
15	Inhibition of intestinal tone, motility and prostaglandin biosynthesis by 5,8,11,14-eicosatetraynoic acid (TYA) 1974 ·Prostaglandins ·A.L. Willis, Pamela Davison, Peter W. Ramwell	20
16	An endoperoxide aggregator (LASS), formed in platelets in response to thrombotic stimuli-purification, identification and unique biological significance 1974 ·Prostaglandins ·A.L. Willis, Douglas C. Kuhn, Floie M. Vane, C. G. SCOTT, (unknown)	138
17	A congenital defect in platelet prostaglandin production associated with impaired hemostasis in storage pool disease 1973 ·Prostaglandins ·A.L. Willis, Harvey J. Weiss	39
18	Interaction between prostaglandins E and F given intradermally in the rat 1971 ·British Journal of Pharmacology ·(unknown), A.L. Willis	60
19	Formation and release of prostaglandins by platelets in response to thrombin. 1970 ·PubMed ·J. Bryan Smith, A.L. Willis	76
20	Actions and interactions of prostaglandins administered intradermally in rat and in man. 1969 ·PubMed ·(unknown), A.L. Willis	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact